Quoin Pharmaceuticals, Ltd.
QNRX
$6.63
$0.030.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.96M | -8.70M | -8.28M | -8.41M | -8.69M |
| Total Depreciation and Amortization | 100.00K | 100.70K | 101.70K | 102.70K | 103.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.01M | 944.10K | 826.30K | 704.40K | 623.00K |
| Change in Net Operating Assets | -2.10K | -1.19M | -636.70K | 51.50K | 95.60K |
| Cash from Operations | -7.86M | -8.84M | -7.99M | -7.55M | -7.86M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.89M | 3.93M | 1.33M | 1.21M | 2.19M |
| Cash from Investing | -1.89M | 3.93M | 1.33M | 1.21M | 2.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -600.00K | -600.00K | -725.00K | -650.00K | -600.00K |
| Issuance of Common Stock | 11.57M | 5.50M | 5.50M | 5.48M | 5.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -32.60K | -32.60K | -32.60K | -32.60K |
| Cash from Financing | 10.97M | 4.86M | 4.74M | 4.80M | 5.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.22M | -46.70K | -1.91M | -1.54M | -459.40K |